The beta-agonist controversy

被引：51

作者：

Taylor, DR

Sears, MR

Cockcroft, DW

机构：

[1] MCMASTER UNIV,ST JOSEPHS HOSP,DEPT MED,HAMILTON,ON,CANADA

[2] FIRESTONE REG CHEST & ALLERGY UNIT,HAMILTON,ON,CANADA

[3] UNIV SASKATCHEWAN,DEPT MED,SASKATOON,SK S7N 0W0,CANADA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1996年 / 80卷 / 04期

关键词：

D O I：

10.1016/S0025-7125(05)70465-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The place of beta-agonist drug therapy in the management of asthma has been a major source of debate and therapeutic uncertainty during the 1990s. The possible adverse effects of these drugs on control of asthma and lung function are reviewed, and potential mechanisms for these effects are discussed. A hypothesis is proposed linking epidemiologic trends in asthma morbidity and mortality rates to beta-agonist drug use.

引用

页码：719 / &

页数：32

共 126 条

[1]

Adcock I. M., 1994, European Respiratory Journal, V7, p421S

[2] INCREASE IN HOSPITAL ADMISSIONS FOR CHILDHOOD ASTHMA - TRENDS IN REFERRAL, SEVERITY, AND READMISSIONS FROM 1970 TO 1985 IN A HEALTH REGION OF THE UNITED-KINGDOM [J].